ShopZone - Онлайн магазин за маркови дрехи и обувки - ПРОМО КОД с отстъпка -10%. Купете нещо за себе, зарадвайте Ваш любим човек, само днес 23.06 и утре 24.06 продуктите в Shopzone.bg
Discovery of Apararenone (MT-3995) as a Highly Selective, Potent, and Novel Nonsteroidal Mineralocorticoid Receptor Antagonist | Journal of Medicinal Chemistry
![Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art Review | Journal of the American College of Cardiology Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art Review | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/fde3d39e-1770-41d5-af05-22df98622142/fx1.jpg)
Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art Review | Journal of the American College of Cardiology
![Identification of Benzoxazin-3-one Derivatives as Novel, Potent, and Selective Nonsteroidal Mineralocorticoid Receptor Antagonists | Journal of Medicinal Chemistry Identification of Benzoxazin-3-one Derivatives as Novel, Potent, and Selective Nonsteroidal Mineralocorticoid Receptor Antagonists | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm2011645/asset/images/large/jm-2011-011645_0006.jpeg)
Identification of Benzoxazin-3-one Derivatives as Novel, Potent, and Selective Nonsteroidal Mineralocorticoid Receptor Antagonists | Journal of Medicinal Chemistry
![Identification of Benzoxazin-3-one Derivatives as Novel, Potent, and Selective Nonsteroidal Mineralocorticoid Receptor Antagonists | Journal of Medicinal Chemistry Identification of Benzoxazin-3-one Derivatives as Novel, Potent, and Selective Nonsteroidal Mineralocorticoid Receptor Antagonists | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm2011645/asset/images/large/jm-2011-011645_0016.jpeg)
Identification of Benzoxazin-3-one Derivatives as Novel, Potent, and Selective Nonsteroidal Mineralocorticoid Receptor Antagonists | Journal of Medicinal Chemistry
![Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction | NEJM Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2003/nejm_2003.348.issue-14/nejmoa030207/production/images/img_medium/nejmoa030207_t1.jpeg)
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction | NEJM
![The impact of thyroid hormone dysfunction on ischemic heart disease in: Endocrine Connections Volume 8 Issue 5 (2019) The impact of thyroid hormone dysfunction on ischemic heart disease in: Endocrine Connections Volume 8 Issue 5 (2019)](https://ec.bioscientifica.com/fileasset/ec/EC_new-EIC.png)
The impact of thyroid hormone dysfunction on ischemic heart disease in: Endocrine Connections Volume 8 Issue 5 (2019)
Pyclen-Based Ln(III) Complexes as Highly Luminescent Bioprobes for In Vitro and In Vivo One- and Two-Photon Bioimaging Applications | Journal of the American Chemical Society
![Frontiers | Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study Frontiers | Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study](https://www.frontiersin.org/files/Articles/598438/fmed-07-598438-HTML/image_m/fmed-07-598438-g001.jpg)
Frontiers | Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study
![Frontiers | Evaluation of ketoconazole as a treatment for Cushing's disease in a retrospective cohort Frontiers | Evaluation of ketoconazole as a treatment for Cushing's disease in a retrospective cohort](https://www.frontiersin.org/files/Articles/1017331/fendo-13-1017331-HTML-r2/image_m/fendo-13-1017331-g001.jpg)
Frontiers | Evaluation of ketoconazole as a treatment for Cushing's disease in a retrospective cohort
![Frontiers | Fluconazole for Hypercortisolism in Cushing's Disease: A Case Report and Literature Review Frontiers | Fluconazole for Hypercortisolism in Cushing's Disease: A Case Report and Literature Review](https://www.frontiersin.org/files/Articles/608886/fendo-11-608886-HTML/image_m/fendo-11-608886-g001.jpg)